Anaphylaxis References

pdfASCIA HP Anaphylaxis References 2021202.78 KB  

Anaphylaxis. Emergency management for health professionals wall chart. (2018). Australian Prescriber, 41 (54), https://www.nps.org.au/assets/b3df19317d2acbf9-8dbd289b4af7-A3-Anaphylaxis-Wallchart-2018.pdf

Anagnostou, K. & Turner, P. (2019). Myths, facts and controversies in the diagnosis and management of anaphylaxis. British Med J, 104, 83-90. https://adc.bmj.com/content/archdischild/104/1/83.full.pdf

Avery, N. J., King, R. M., Knight, S., & Hourihane, J. O. (2003). Assessment of quality of life in children with peanut allergy. Pediatr Allergy Immunol, 14(5), 378-382 . https://doi.org/10.1034/j.1399-3038.2003.00072.x

Baumgart, K., Brown, S., Gold, M. & Zeigler, J., ASCIA guidelines for prevention of food anaphylactic reactions in schools, preschools and child‐care centres (2004) J Paediatr Child Health, 40, 669-671. https://doi.org/10.1111/j.1440-1754.2004.00509.x

Bock, S. A., Munoz-Furlong, A., & Sampson, H. A. (2001). Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol, 107(1), 191-3. https://www.jacionline.org/article/S0091-6749(01)14683-X/pdf

Bock, S. A., Munoz-Furlong, A., & Sampson, H. A. (2007). Further fatalities, caused by anaphylactic reactions to food, 2001-2006. J Allergy Clin Immunol, 119(4), 1016-1018. https://doi.org/10.1016/j.jaci.2006.12.622

Bock, S. A., Kelso, J. M., & Feldweg, A. M. (ed). (2010). Fatal Anaphylaxis. UpToDate.  https://www.uptodate.com/contents/fatal-anaphylaxis

Boyce, J. A., Assa'ad, A., Burks, A. W., Jones, S. M., Sampson, H. A., Wood, R. A., … Schwaninger, J. M. (2010). Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol, 126(6 Suppl), S1-S58. https://dx.doi.org/10.1016%2Fj.jaci.2010.10.007

Brooke-Taylor, S. (2007). Development of VITAL allergen action levels grid: Explanatory notes. Updated 2019. http://allergenbureau.net/vital/vital-science/

Brown, S. G. A., Blackman, K. E., Stenlake, V., & Heddle, R. J., (2004). Insect sting anaphylaxis; prospective evaluation of treatment with intravenous adrenaline and volume resuscitation. Emerg Med J, 000, 1-7. https://emj.bmj.com/content/emermed/21/2/149.full.pdf

Brown, S. G. A., Mullins, R. J., & Gold, M. S. (2006). Anaphylaxis: diagnosis and management. MJA, 185(5), 283-289. https://www.mja.com.au/system/files/issues/185_05_040906/bro10212_fm.pdf

Campbell, D. E., Anaphylaxis Management: Time to Re-evaluate the Role of Cortiscosteroids. J Allergy Clin Immunol, 104, 83-90. https://www.jaci-inpractice.org/article/S2213-2198(19)30621-X/pdf

Coop, C. A., Schapira, R. S., & Freeman, T. M. (2017). Are ACE Inhibitors and Beta-blockers Dangerous in Patients at Risk for Anaphylaxis? J Allergy Clin Immunol Pract. 5(5), 1207-1211. https://doi.org/10.1016/j.jaip.2017.04.033

Frith K, Smith J, Joshi P, Ford LS, Vale S. Updated anaphylaxis guidelines: management in infants and children. Aust Prescr 2021;44:91-5. www.nps.org.au/australian-prescriber/articles/updated-anaphylaxis-guidelines-management-in-infants-and-children

https://doi.org/10.18773/austprescr.2021.016

Heddle, R. J., Anaphylaxis to stings and bites. (2006). MJA, 185(5), 290. https://www.sciencedirect.com/science/article/abs/pii/S2213219817303495

Hu, W., & Kemp, A., Managing childhood food allergies and anaphylaxis. (2005). Australian Family Physician, 34 (1-2), 1-5. https://www.semanticscholar.org/paper/Managing-childhood-food-allergies-and-anaphylaxis.-Hu-Kemp/21c40e485ed68b5057486e9080a52045f6957737

Jacobsen, K. H., Sambell, R., Devince, A., & Vale, S. (2018). Food Allergy Readiness and Anaphylaxis Management in early childhood education and care in Western Australia. Australasian Journal of Early Childhood,  https://doi.org/10.23965%2FAJEC.43.4.05

Jarvinen, K. M., Sicherer, S. H., Sampson, H. A., & Nowak-Wegrzyn, A., (2008). Use of multiple doses of epinephrine in food-induced anaphylaxis in children. J Allergy Clin Immunol, 122(1), 131-138. https://doi.org/10.1016/j.jaci.2008.04.031

Hompes, S., Kohli, A., Nemat, K., Scherer, K., Lange, L., Rueff, F., … Worm, M. (2011). Provoking allergens and treatment of anaphylaxis in children and adolescents - data from the anaphylaxis registry of German-speaking countries. Ped Allergy Immunol.  https://doi.org/10.1111/j.1399-3038.2011.01154.x

Kemp, A. S., Action on Anaphylaxis Action Plans (2010), J Paediatr Child Health, 46(10),554-556. https://doi.org/10.1111/j.1440-1754.2009.01690.x

Lieberman, P., Nicklas, R. A., Oppenheimer, J., Kemp, S. F., & Land, D. M. (2010). The diagnosis and management of anaphylaxis practice parameter: 2010 update. https://doi.org/10.1016/j.jaci.2010.06.022

Liew, W. K., Williamson, E. W., & Tang, M. L. K. (2008). Anaphylaxis fatalities and admissions in Australia. J Allergy Clin Immunol, 123(2), 434-442. https://www.jacionline.org/article/S0091-6749(08)01929-5/pdf

Loh, R., Mullins, R. J., & Vale, S., (2012). Anaphylaxis. Investigating and managing an allergic emergency. Med Today, 13(9), 16-25. https://medicinetoday.com.au/2012/september/feature-article/anaphylaxis-investigating-and-managing-allergic-emergency

McCall, S.J., Kurinczuk, J.J. & Knight, M., (2019). Anaphylaxis in Pregnancy in the United States: Risk Factors and Temporal Trends Using National Routinely Collected Data. J Allergy Clin Immunol, 7 (8), 2606-2612.e3. https://doi.org/10.1016/j.jaip.2019.04.047

Mullins, R. J., Anaphylaxis: risk factors for recurrence. (2003). Clin Exp Allergy, 33(8), 1033-1040. https://onlinelibrary.wiley.com/doi/10.1046/j.1365-2222.2003.01671.x

Mullins, R. J., Clark, S., & Camargo, C.A., (2009). Regional variation in epinephrine autoinjector prescriptions in Australia: more evidence for the vitamin D-anaphylaxis hypotheses. Ann Allergy Asthma Immunol, 103(6), 488-495. https://doi.org/10.1016/S1081-1206(10)60265-7

Mullins, R. J., Dear, K. B. G., & Tang, M. L. K. (2015). Time trends in Australia hospital anaphylaxis admissions in 1998-1999 to 2011-2012. J Allergy Clin Immunol, 136(2), 367-375. https://doi.org/10.1016/j.jaci.2015.05.009   

Mullins, R. J., Wainstein, B. K., Barnes, E. H., Liew, W. K., & Campbell, D. E. (2016). Increases in anaphylaxis fatalities in Australia from 1997 to 2013. Clin Exp Allergy. 46(8), 1099-1110. https://doi.org/10.1111/cea.12748

Osborne, N. J., Koplin, J. J., Martin, P. E., Gurrin, L. C., Thiele, L., Tang, M. L.K., … Allen, K. J., (2010). The HealthNuts population-based study of paediatric food allergy: validity, safety and acceptability. Clin Exp Allergy, 40(10),1516-1522. https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2222.2010.03562.x

Pharmaceautical Benefits Scheme (PBS) for health professionals. Canberra: Australian Government Department of Health and Ageing. http://www.pbs.gov.au/pbs/home.

Poulos, L. M., Waters, A. M., Correll, P.K., Loblay, R. H., & Marks, G. B. (2007). Trends in hospitalizations for anaphylaxis, angioedema, and urticaria in Australia, 1993-1994 to 2004-2005. J Allergy Clin Immunol, 120(4), 878-884. https://doi.org/10.1016/j.jaci.2007.07.040

Primeau, M. N., Kagan, R., Joseph, L., Lim, H., Dufresne, C., Duffy, C., … Clarke, A. (2000). The psychological burden of peanut allergy as perceived by adults with peanut allergy and the parents of peanut-allergic children. Clin Exp Allergy, 30(8), 1135-1143. https://www.ncbi.nlm.nih.gov/pubmed/30538699

Pumphrey, R. S. H.  (2003). Fatal posture in anaphylactic shock. J Allergy Clin Immunol, 112 (2), 451-452. https://www.jacionline.org/article/S0091-6749(03)90000-5/pdf

Pumphrey, R. S. H. (2004). Anaphylaxis: can we tell who is at risk of a fatal reaction? Curr Opin Allergy Clin Immunol, 4(4), 285-290. https://doi.org/10.1097/01.all.0000136762.89313

Pumphrey, R. S. H., & Gowland, M. H. (2007). Further fatal allergic reactions to food in the United Kingdom, 1999-2006. J Allergy Clin Immunol, 119(4), 1018-1019. https://doi.org/10.1016/j.jaci.2007.01.021

Pumphrey, R. S. H. & Sturm, G. (2014). Risk factors for fatal anaphylaxis in Moneret-Vautrin, D.A. (ed) Advances in Anaphylaxis Management. Future Medicine, 32-48. https://doi.org/10.1016/j.jaci.2007.01.021

Sampson, H. A., Mendelson, L., & Rosen, J. P. (1992). Fatal and near fatal anaphylactic reactions to food in children and adolescents. N Engl J Med, 327(6), 380-384. https://www.nejm.org/doi/full/10.1056/nejm199208063270603

Sampson, H. A., Munoz-Furlong, A., Campbell, R. L., Adkinson, N. F., Bock, S. A., Branum, A., … Decker, W. W. (2006) Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol, 117(2), 391-397. https://doi.org/10.1016/j.jaci.2005.12.1303

Savage, J. H., Matsui, E. C., Skripak, J. M., & Wood, R. A. (2007). The natural history of egg allergy, J Allergy Clin Immunol, 120(6), 1413-1417. https://doi.org/10.1016/j.jaci.2013.12.1041

Shaker, M. S., Wallace, D. V., Golden, D. B. K., Stukus, D. R., & Wang, J. (2020). Anaphylaxis—a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis. J Allergy Clin Immunol, 145(4), 1082-1123. https://www.jacionline.org/article/S0091-6749(20)30105-6/fulltext

Sheikh, A., Hippisley-Cox, J., Newton, J., & Fenty, J. (2008). Trends in national incidence, lifetime prevalence and adrenaline prescribing for anaphylaxis in England. J R Soc Med, 101(3), 139-143. https://dx.doi.org/10.1258%2Fjrsm.2008.070306

Simons, F. E. R., First-aid treatment of anaphylaxis to food: focus on epinephrine. (2004). J Allergy Clin Immunol, 113(5), 837-844. https://doi.org/10.1016/j.jaci.2004.01.769

Simons, K. J., & Simons, F. E. R. (2010). Epinephrine and it use in anaphylaxis: current issues. Curr Opin Allergy Clin Immunol, 10(4), 354-361. https://journals.lww.com/co-allergy/Abstract/2010/08000/Epinephrine_and_its_use_in_anaphylaxis__current.16.aspx

Simons, F. E. R., & Schatz, M. (2012). Anaphylaxis during pregnancy. J Allergy Clin Immunol, 130(3), 597-606. https://www.jacionline.org/article/S0091-6749(12)01042-1/pdf

Simons, F. E. R., Ardusso, L. R. F., Dimov, V., Ebisawa, M., El-Gamal, Y. M., Lockey, R. F., & Worm, M. (2013). WAO Anaphylaxis guidelines: 2013 update of the evidence base. Int Arch Allergy Immunol, 162(3), 193-204.   https://doi.org/10.1159/000354543

Skripak, J. M., Matsui, E. C., Mudd, K., & Wood, R. (2007). The natural history of IgE-mediated cow's milk allergy. J Allergy Clin Immunology, 120(5), 1172-1177.  https://doi.org/10.1016/j.jaci.2007.08.023

Stuckey, M., Cobain, T., Sears, M., Cheney, J., & Dawkins, R. L. (1982). Bee venom hypersensitivity in Busselton. Lancet 3(2), 41.  https://doi.org/10.1016/S0140-6736(82)91172-2

Summers, C. W., Pumphrey, R. S. H., Woods, C. N., McDowell, G., Pemberton, P. W., & Arkwright, P. D. (2008). Factors predicting anaphylaxis to peanuts and tree nuts in patients referred to a specialist center. J Allergy Clin Immunol, 121(3), 632-8 e2. https://doi.org/10.1016/j.jaci.2007.12.003

Thomson, H., Seith, R., & Craig, S., (2017). Inaccurate diagnosis of paediatric anaphylaxis in three Australian emergency departments. J Paedriatr Child Health, 52(7), 698-704. https://doi.org/10.1111/jpc.13483

Thong, B., & Tan, T. (2011). Epidemiology and risk factors for drug allergy. Br J Clin Pharmacol, 71(5), 684-700. https://doi.org/10.1111/j.1365-2125.2010.03774.x 

Tole, J. W., & Lieberman, P. (2007). Biphasic anaphylaxis: Review of incidence, clinical predictors and observation recommendations. Immunol Allergy Clin North Am. 27(20), 309-326, viii  https://doi.org/10.1016/j.iac.2007.03.011

Turner, P. J., Jerschow, E., Umasunthar, T., Lin, R., & Campbell, D., (2017). Fatal Anaphylaxis: Mortality Rate and Risk Factors. J Allergy Clin Immunol Prac, 5(5), 1169-1178.  https://doi.org/10.1016/j.jaip.2017.06.031

Turner, P. J., Campbell, D. E., Motosue, M. S., & Campbell, R. L. (2020). Global Trends in Anaphylaxis Epidemiology and Clinical Implications. J Allergy Clin Immunol, pii: S2213-2198 (19) 30967-5. https://doi.org/10.1016/j.jaip.2019.11.027

Umasunthar, T., Leonardi-Bee, J., Hodes, M., Turner, P. J. Core, C., Warner, J. O., & Boyle, R. J. (2013). Incidence of fatal food anaphylaxis in people with food allergy: a systematic review and meta-analysis. Clin Exp Allergy, 43(12), 1333-1341. https://doi.org/10.1111/cea.12211

Vitte, J., & Bongrand, P. (2013). Serum trypase determination in patients with acute allergic reactions. J Allergy and Clinical Immunol, 131(6). https://doi.org/10.1016/j.jaci.2013.03.028

Vale, S., Smith, J., & Loh, R. (2012). Safe use of adrenaline autoinjectors. Australian Prescriber, 35, 56-58. https://doi.org/10.18773/austprescr.2012.025

Vale, S., Smith, J., Said. M., Dunne, G., Mullins, R. J., & Loh, R., (2015). ASCIA guidelines for prevention of anaphylaxis in schools, pre-schools and childcare: 2015 update. J Paed Child Health. 51(10), 949-954.  https://doi.org/10.1111/jpc.12962

World Allergy Organization (WAO) Anaphylaxis Guidance 2020 https://www.worldallergyorganizationjournal.org/article/S1939-4551(20)30375-6/fulltext  

Yunginger, J. W., Squillace, D. L., Jones, R. T., & Helm Ricki, M., (1989). Fatal anaphylaxis induced by peanuts, Allergy & Asthma Proceedings, 10(4), 249-253. https://doi.org/10.2500/108854189778959993

Content updated June2021 

Mod ASCIA Member
Donate to AIFA
go to NAS website
ASCIA Member Login
ASCIA Update

Information for the community about allergic diseases, immunodeficiencies and other immune diseases.
See latest edition here...
Join our mailing list:

About ASCIA

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links

About ASCIA

ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Accreditiation

healthdirect

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.